Google
Trusted Resources: News & Events
Latest announcements and gatherings
University Hospitals program uses music to teach about sickle cell (photos, video)
The study looked at Seidman’s BEATS (Build, Educate, Advance, Transition in Sickle cell disease) music therapy program, developed by Rodgers-Melnick. BEATS focuses on young adults ages 18-35 who have transitioned from pediatric care at Rainbow Babies and Children’s Hospital to an adult care program at Seidman.
To help young adults with their transition to adult care, doctors at Seidman developed the “Bridge Clinic,” a care team that includes a hematologist, nurses and social worker, as well as one-hour BEATS music therapy sessions that Rodgers-Melnick leads.
Each week, BEATS participants create a different song about how the disease affects the body, what to do if they develop a fever or pneumonia, pain management techniques and other topics. The program currently has 50 participants.
+myBinderRelated Content
-
Study Confirms Safe Use of Opioids for Pain Control in Sickle Cell DiseaseThe most common cause of hospital admiss...
-
The clinical and biochemical effects of treatment with omega-3 fatty acids in patients with homozygous sickle cell d...Background: Chronic inflammation, coagu...
-
The Association Between Timely Opioid Administration and Hospitalization in Children With Sickle Cell Disease Presen...Objective: To evaluate the association ...
-
Prodigy’s death shines light on slow progress against sickle cell diseaseThe death of the rap artist Prodigy (Alb...
-
MaxCyte, Inc. to Present Positive Preclinical Data for Sickle Cell DiseaseMaxCyte, a US-based global company dedic...
-
Calimmune Expands Lentiviral Gene Therapy Pipeline Through License of Sickle Cell Disease Therapeutic CandidateLicense of Gamma-Globin from Cincinnati ...
-
What it’s like to be 17 and living with sickle cell diseaseTre Adegoroye is 17 and was diagnosed wi...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.